Further prospective studies should recruit patients with different stages of CKD to determine the potential of PSP/REG Iα as a biomarker for diagnosis and evaluation of the onset and development of CKD in pregnant women. The gene discussed is REG1A; the disease is supranuclear palsy, progressive, 1.